Moderna vaccine have lower risk of breakthrough infections and hospitalizationsPosted by Annie May / January 23, 2022
A recent study has shown that Moderna vaccines have a lower risk of both breakthrough infections and hospitalizations.
According to an Israeli healthcare provider, more than 90% of patients sick with COVID showed remarkable improvement within 3 days of taking Pfizer’s new antiviral pill.
President Biden has doubled the federal order of Pfizer’s new COVID pill, along with expediting their shipment and distribution as omicron surges.
COVID cases have spiked 948% in Florida, while 7-day hospitalizations have increased by 40% (between Christmas and New Years alone). The omicron vaccine is ripping through the population at an alarming rate, which has led to a spike in children being sent to the hospital.
The United States has clocked nearly half a million COVID cases, a high for any country at any time during the pandemic. Within the last week, 1 in 50 Manhattan residents have been infected with COVID, a sign of just how infectious the new variant is. Meanwhile, France is reporting record high COVID cases as omicron sweeps through Europe.
So far, omicron has been detected in 89 countries, and cases are doubling every 1.5-3 days in places experiencing community transmission. According to a new study, the omicron variant is no safer than the delta variant, and it is five times more likely to reinfect people who have already had COVID.
The Omicron variant grows 70x faster than the delta variant, which may account for its fast spread. In the final analysis of its COVID pill, Pfizer says the drug is highly effective, even against Omicron, and it should be released before the end of the year.
Before Omicron, Pfizer reported a 90% reduction in hospitalizations and death in high-risk COVID patients. In terms of the vaccine, Pfizer’s CEO announced that the government ordered enough COVID vaccine doses for every child aged 5 to 11 in the country. That’s about to be put to the test––kids have started getting the COVID vaccine.